Antiplatelet Drugs Flashcards
Classify antiplatelet drug’s
- Thromboxane synthesis inhibitors
- phosphodiesterase inhibitors
- purinergic receptor antagonist
- glycoprotein IIb/IIIa Receptor antagonist
Name thromboxane synthesis inhibitor’s
Low-dose aspirin
Name a phosphodiester inhibitor
Dipyrimadole
Name purinergic receptor antagonist
- Ticlopidine
- Clopidogrel
- Prasugrel
- Cangrelor
- Ticagrelor 
Name glycoprotein IIb/IIIa receptor antagonist
- Abciximab 
- Eptifibatide
- Tirofiban
What is the mechanism of action of aspirin
Irreversibly Acetylates platelet COX-1 and reduces the production of TXA2.
Why is aspirin at higher levels not as effective
Because it inhibits both TXA2 and PGI2
What is the mechanism of action of dipyrimadole 
Vasodilator. It inhibits phosphodiesterase and increases the concentration of cyclic AMP
What is the mechanism of action of purinergic receptor antagonist
The inhibit ADP mediated playing the aggregation by irreversibly blocking purinergic receptors on platelets
Which drugs produce a synergistic effect with purinergic receptor antagonist
- Aspirin
- glycoprotein IIb/ IIIa antagonists
What are the adverse effects of purinergic receptor antagonist
- Diarrhoea
- thrombocytopenia
- neutropenia
What is the mechanism of action of glycoprotein receptor antagonist
- Block glycoprotein receptors IIb/IIIa for fibrinogen and von Willibrands factor on platelet surface
- inhibit the final step in the process of platelet aggregation produced by platelet agonists
What are the uses Glycoprotein receptor antagonist
- Percutaneous coronary intervention
- unstable angina
- acute myocardial infarction
What Are the uses of anti-platelet drugs
- Acute coronary syndrome (Acute myocardial infarction, angina)
- Coronary artery disease
- prosthetic heart valve
- transit ischaemic attack
- peripheral artery disease
What should we give into a patient with non-ST elevation myocardial infarction
Dual antiplatelet therapy. Aspirin With purinergic receptor antagonist for at least a year